Related Experiment Video

Updated: Apr 8, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.4K

Oocyte-inspired universal whole-cell vaccines against tumor heterogeneity

Sishi Guo1, Qi Lei2, Yun Chen3

  • 1MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, People's Republic of China.

Proceedings of the National Academy of Sciences of the United States of America
|April 6, 2026
PubMed

Insights

Scientists developed biomimetic whole-tumor cell vaccines inspired by oocyte structure. These advanced vaccines preserve tumor antigens and enhance immune response, offering potential for personalized cancer therapy and prevention.

Area of Science:

  • Oncology
  • Immunology
  • Biomaterials Science

Background:

  • Tumor heterogeneity presents a significant challenge in cancer therapy, often leading to immune evasion.
  • Current cell-based vaccines struggle with antigen loss and inadequate immune activation, limiting their clinical efficacy.
  • Existing treatments face difficulties in addressing the diverse antigenic profiles of heterogeneous tumors.

Purpose of the Study:

  • To develop novel biomimetic whole-tumor cell vaccines that overcome antigen loss and enhance immune activation.
  • To create vaccines preserving the complete repertoire of tumor-specific antigens for personalized cancer treatment.
  • To engineer vaccines with tunable properties for improved phagocytosis, antigen processing, and presentation.

Main Methods:

  • Development of biomimetic shells inspired by the zona pellucida structure for whole-tumor cells.
  • Optimization of cellular mechanics to enhance phagocytosis and antigen processing.
  • Application of cryo-inactivation to disrupt intracellular architecture and improve antigen presentation.
  • Creation of universal vaccines from heterogeneous tumor cells shaped by microenvironmental pressures.

Main Results:

  • Biomimetic vaccines successfully preserved the complete patient-specific antigen profiles of whole-tumor cells.
  • Optimized cellular mechanics and cryo-inactivation enhanced antigen processing and presentation efficiency.
  • The developed vaccines demonstrated the ability to generate tailored immune responses for individualized therapy.
  • Universal vaccines showed poly-valent efficacy against diverse tumor heterogeneity, indicating therapeutic and preventive potential.

Conclusions:

  • Biomimetic whole-tumor cell vaccines offer a promising strategy to address tumor heterogeneity and antigen loss.
  • These vaccines facilitate personalized immunotherapy by preserving unique tumor antigen profiles.
  • The engineered vaccines hold significant potential for both the treatment and prevention of various cancers.
Keywords:
cancercellular encapsulationheterogeneous cancervaccine

More Related Videos

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

2.0K
Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

4.2K

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
10.1K
Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
18.6K